August 21, 2014

Rotavirus Vaccine Deceit: Textbook Example of What’s Wrong with the Vaccine Industry

pin it button Rotavirus Vaccine Deceit: Textbook Example of What’s Wrong with the Vaccine Industry

Hiding Vax Needles Like Knives Rotavirus Vaccine Deceit: Textbook Example of What’s Wrong with the Vaccine Industry

Photo of man in jeans (original knives replaced by hypodermics) by David Goehring

Rotavirus Vaccine: Diarrhea of Deceit

by Jagannath Chatterjee
Gaia-Health.com

The rotavirus vaccine is a textbook example of what’s wrong with the vaccine industry. It works for only a limited number of rotavirus types, causes severe adverse effects including death, was approved via corrupt agencies & officials with financial ties to the manufacturer—and it results in far more cases of a far more deadly disease.

When doctors prescribe the Rotavirus vaccine as a preventive against diarrhea, the deception begins. Parents are not informed that diarrhea can be caused by a host of factors, including bacterial and viral infections. Bacterial infections resulting from unclean water are more harmful. Viral infections leading to diarrhea do not pose any danger if the child is treated with an oral rehydration solution or is breastfed, which can prevent dehydration.

There are many strains of rotavirus and most are yet to be identified. Besides the rotavirus strains, diarrhea can also be caused by astroviruses, calciviruses, other pathogens, and toxins. The rotavirus vaccine, delivered orally, contains just four of the many rotavirus strains and can protect against only these strains, leaving the child unprotected against the major factors.

The first rotavirus vaccine was licensed in the USA in 1998 and was recommended in March 1999. Parents did not know that this vaccine was recommended by ignoring serious side effects noticed in clinical trials. As a result many children suffered inversion of part of the intestine into an adjacent section—a condition called intussusception—a very serious, painful, and often fatal condition. Deaths for unexplained reasons were reported. Consequently the vaccine was withdrawn in October 1999.

When the US Congress investigated, serious procedural problems and negligence came to the fore, prompting a hearing on June 15, 2000. It revealed that both the FDA and CDC, US regulatory bodies, were aware about the vaccine’s serious adverse effects. There was also conflict of interest as two members on the advisory committee profited from the decision. Dr. Kathryn Edwards had received research funds worth $255,000 per year from the vaccine manufacturer. Dr. Paul Offit held a patent on another rotavirus vaccine and his travel around the country to advise about vaccine safety was funded by vaccine manufacturers. Moreover, 60% of FDA advisory committee members and 50% of CDC members had financial ties with the manufacturers of the vaccine. Clearly, the greed of both officials and the pharmaceutical industry prompted the flouting of all rules and the health of children took second place.

One would have expected serious action on the basis of these findings, but nothing happened. The erring agencies, which ought to maintain very high standards of honesty and integrity, instead justified their actions by saying that there was no bar to officials with ties to the industry recommending vaccines. In 2006 two more versions of the vaccine, containing live viruses and orally administered, were out in the market and recommended by those very tainted officials and doctors.

A peep into the clinical trials revealed alarming facts:

  • The vaccine had not been compared to an inert placebo, but against the same vaccine with all the ingredients, minus the virus so that it could be declared safer than it was.
  • The viruses used were an assortment of human and cow viruses propagated in cells of African green monkeys, the same specimen that has resulted in the oral polio vaccine (OPV) being contaminated with monkey viruses.
  • The cells are kept alive in a cow serum medium, which further opens the door to unknown viruses.
  • The chemical ingredients of the vaccine contain polysorbate 80, a known reproductive toxin.

The clinical trials have recorded a lower incidence of intestinal blockage, signifying that even the new vaccine is not free from that risk. Vaccinated children have a three times greater risk of suffering from intestinal bleeding, even after accounting for many cases that were denied by the supervising team. The trials revealed:

  • Gangrene and necrosis of the intestines
  • Severe vomiting leading to hospitalization
  • Seizures caused by abnormal electrical discharges in the brain that in some cases became chronic
  • Eczema
  • Diarrhea (the very disease the vaccine is supposed to prevent)
  • Frequent ear infections
  • Difficulty in breathing
  • Asthma
  • Nasopharyngitis, which is a viral infectious disease of the upper respiratory tract

Recent media reports have noted that the use of this vaccine in the USA has caused an alarming increase in cases of a far more lethal norovirus infection, which is causing 21 million cases and 800 deaths annually—against the 20 to 40 annual deaths that occur from rotavirus infections. There has also been a dramatic increase in cases of inflammatory bowel disease.  Instead of reviewing the situation and withdrawing the rotavirus vaccine, which has caused the shift to a more lethal virus, a vaccine for norovirus has been developed and is ready for marketing.

Alarmed by the adverse effects of the vaccine in India and noting that rotavirus-related diarrhea is easily treated without complications, not to mention that the rates for India are based upon estimates kept high to alarm the public, ethical Indian doctors have pointed out that the high cost of the vaccine makes it prohibitive and not cost effective. A study has revealed that the incidence of diarrhea and related deaths in India is directly related to poverty, lack of clean drinking water, and sanitation, and that in most cases it requires the presence of other pathogens for rotavirus to cause diarrhea.

Doctors trying to report cases of adverse effects have been stopped from doing so by the Indian Academy of Pediatrics (IAP) – an agency that is entirely dependent on funds from vaccine manufacturers for its operations—under the plea that the safety profile of the vaccine should not be tarnished! The IAP is lobbying for its inclusion in the government program.

Recently, to counter the cost effectiveness argument, Indian scientists provided great publicity to an indigenously prepared and low priced rotavirus vaccine. Even as the publicity, backed by the Department of Biotechnology in India, was picked up by the national and international press, it emerged that the results of the clinical trials are yet to be made public. It has also been pointed out that the vaccine has only one rotavirus strain, and has been tested on 4,532 infants, whereas to fully determine the adverse events it needs to be tested on more than 50,000. Incidentally, the Indian vaccine requires that mothers stop breastfeeding their children during its period of administration and for a time afterwards—a highly controversial aspect.

Providing publicity to clinical trial findings before the results are published is a violation of medical ethics. This would make it difficult for a peer reviewed journal to publish the findings. The involvement of controversial agencies like PATH and the Bill & Melinda Gates Foundation in the evolution of this vaccine has also riled the health activists because of their recent active connivance with government agencies in India to illegally test the highly controversial and unsafe cervical cancer vaccine on tribal girls in Andhra Pradesh and Gujarat without parental consent, which resulted in several deaths and adverse effects.

It remains to be seen whether the industry-backed attempt to mass administer a questionable and unsafe corporate product for diarrhea prevention will succeed and take preference over genuine public health needs, like eradication of poverty, provision for clean water and sanitation, and nutrition for the mother and child. Now the ball is in the court of the government of India, which sadly has a tainted record for allowing the administration of the OPV, which has caused paralysis cases in the country to soar from 3,000 to 60,000 cases annually, and is now claiming credit for a “polio free” India.

Read the full article here: http://gaia-health.com/gaia-blog/2013-07-01/rotavirus-vaccine-diarrhea-of-deceit/

Sources:

  1. Dramatic Increase in Hospitalization of US Children With Inflammatory Bowel Disease
  2. Takeda tackling norovirus in bid to grow vaccine biz
  3. A step ahead
  4. Misplaced hoopla over Indian anti-diarrhea vaccine
  5. India cannot afford to use vaccines that are not cost-effective
  6. Vaccine Safety Manual for Concerned Families and Health Practitioners: Guide to Immunization Risks and Protection

Vaccine Epidemic
by Louise Kuo Habakus and Mary Holland J.D.

Vaccine Epidemic bookcover Rotavirus Vaccine Deceit: Textbook Example of What’s Wrong with the Vaccine Industry

FREE Shipping Available!

More Info

0 commentsback to post

Other articlesgo to homepage

Ebola Virus: A Major Threat to the U.S. or Overhyped?

Ebola Virus: A Major Threat to the U.S. or Overhyped?

Pin It

For the third time in the history of the US Centers for Disease Control and Prevention (CDC), the agency has raised its level of emergency alertness to “Level 1″—this time in response to the Ebola virus, following outbreaks in West Africa. On August 8, the World Health Organization (WHO) also declared the Ebola outbreak an international public health emergency.

The Ebola panic is very reminiscent of the 2005 bird flu hoax, and the 2009 H1N1 (swine flu) scare—another Level 1 “emergency” that turned out to be grossly hyped to promote the sales of unnecessary vaccines that turned out to be riddled with horrible side effects, including the devastating sleeping disorder, narcolepsy.

Now, health officials warn that an Ebola outbreak in the US is just “one airline passenger away.” While theoretically plausible, panic should be tempered by the fact that the American medical system is far better equipped to contain a non-airborne virus like Ebola, compared to West Africa. According to Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, it would be “extraordinarily unlikely that it will be an outbreak at all because of the way we take care of people, how we have the capability of isolating them, how we understand what one needs to do to protect the health care providers and the kinds of health care facilities we have.”

The fact is, the CDC is trumping up the fear factor, while simultaneously downplaying its own role in potentially creating a devastating outbreak through its own negligence. Mere weeks ago, the CDC was found to have accidentally released two dangerous pathogens: anthrax and H5N1 avian influenza. Dr. Thomas R. Frieden, head of the CDC, recently issued a report that admits to sloppy work ethics at the lab. If you ask me, we should probably be more afraid of what the CDC does with the Ebola virus than anything.

ALS Ice Bucket Challenge: Do You Know What You Are Supporting?

ALS Ice Bucket Challenge: Do You Know What You Are Supporting?

Pin It

The ALS Ice Bucket Challenge to raise money for the ALS Association is sweeping the nation, and going viral in social media. However, do you know what you are supporting if you contribute funds to the ALS Association? Many people may be surprised to learn that only 27% of the Associations’ funds are spent on research, with over 50% of its expenditures supporting salaries.

Also, if you are pro-life, did you know that the ALS Association supports drug research utilizing stem cells from 8-week old aborted fetuses?

Will India be First Country to Revoke Marketing Licenses for HPV Vaccines?

Will India be First Country to Revoke Marketing Licenses for HPV Vaccines?

Pin It

A petition currently before the Supreme Court of India alleges that the Drugs Controller of India issued licenses for Gardasil and Cervarix without adequate research on safety as directed by the Parliamentary Standing Committee on Health and Family Welfare.

Petition number 558/2012, filed by Kalpana Mehta, Nalini Bhanot and V. Rukmini Rao, seeks to resolve this and several other issues by asking the Supreme Court of India to rescind the licenses for marketing and administration of HPV vaccines, make provisions to identify and treat any girls left with chronic health problems and/or autoimmune disorders after their participation in HPV vaccine trials, blacklist the Program for Appropriate Technology in Health (PATH), and allow no other foreign agencies to have a field presence in India.

Will India be the first country in the world to revoke the marketing licenses for Gardasil and Cervarix? Will the Supreme Court of India move to protect the health and welfare of their young citizens, or the interests of the HPV vaccine manufacturers? Will PATH and similar agencies be banned from operating in India?
Will the victims of adverse reactions to HPV vaccines be located and treated? We can only hope these questions will be answered when the final hearing will take place.

CDC Whistleblower: CDC Covered Up MMR Vaccine Link to Autism in African American Boys

CDC Whistleblower: CDC Covered Up MMR Vaccine Link to Autism in African American Boys

Pin It

A top research scientist working for the Centers for Disease Control and Prevention (CDC) played a key role in helping Dr. Brian Hooker of the Focus Autism Foundation uncover data manipulation by the CDC that obscured a higher incidence of autism in African-American boys.

“We’ve missed ten years of research because the CDC is so paralyzed right now by anything related to autism. They’re not doing what they should be doing because they’re afraid to look for things that might be associated.” The whistleblower alleges criminal wrongdoing of his supervisors, and he expressed deep regret about his role in helping the CDC hide data.

The Cancer Industry is Too Prosperous to Allow a Cure

The Cancer Industry is Too Prosperous to Allow a Cure

Pin It

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it.

read more


Get the news right in your inbox!